Group One Trading’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $745K | Buy |
11,059
+9,353
| +548% | +$623K | ﹤0.01% | 3151 |
|
|
2026
Q1 | $107K | Sell |
1,706
-27,571
| -94% | -$1.92M | ﹤0.01% | 4659 |
|
|
2025
Q4 | $1.94M | Buy |
29,277
+14,278
| +95% | +$923K | ﹤0.01% | 2303 |
|
|
2025
Q3 | $1.01M | Buy |
14,999
+682
| +5% | +$54K | ﹤0.01% | 3023 |
|
|
2025
Q2 | $1.25M | Buy |
+14,317
| New | +$1.12M | ﹤0.01% | 2562 |
|
|
2025
Q1 | – | Sell |
-2,249
| Closed | -$184K | – | 7770 |
|
|
2024
Q4 | $175K | Buy |
2,249
+1,407
| +167% | +$104K | ﹤0.01% | 4052 |
|
|
2024
Q3 | $56.4K | Sell |
842
-1,953
| -70% | -$160K | ﹤0.01% | 4578 |
|
|
2024
Q2 | $317K | Sell |
2,795
-6,177
| -69% | -$781K | ﹤0.01% | 2984 |
|
|
2024
Q1 | $1.24M | Buy |
8,972
+4,064
| +83% | +$511K | ﹤0.01% | 1890 |
|
|
2023
Q4 | $609K | Buy |
4,908
+816
| +20% | +$83.4K | ﹤0.01% | 2906 |
|
|
2023
Q3 | $382K | Buy |
+4,092
| New | +$461K | ﹤0.01% | 3187 |
|
|
2022
Q4 | – | Sell |
-11,073
| Closed | -$1.22M | – | 7424 |
|
|
2022
Q3 | $892K | Sell |
11,073
-36,075
| -77% | -$3.06M | ﹤0.01% | 2687 |
|
|
2022
Q2 | $3.51M | Buy |
47,148
+36,364
| +337% | +$3.32M | 0.01% | 1565 |
|
|
2022
Q1 | $1.38M | Sell |
10,784
-14,228
| -57% | -$1.56M | ﹤0.01% | 2766 |
|
|
2021
Q4 | $3.36M | Buy |
+25,012
| New | +$3.59M | ﹤0.01% | 2072 |
|
|
2021
Q1 | – | Sell |
-187,120
| Closed | -$17.6M | – | 7664 |
|
|
2020
Q4 | $17.3M | Buy |
187,120
+150,568
| +412% | +$13.4M | 0.03% | 518 |
|
|
2020
Q3 | $3.77M | Buy |
36,552
+35,668
| +4,035% | +$3.73M | 0.01% | 1106 |
|
|
2020
Q2 | $90K | Buy |
+884
| New | +$79.1K | ﹤0.01% | 3991 |
|
|
2020
Q1 | – | Sell |
-17,352
| Closed | -$1.08M | – | 5362 |
|
|
2019
Q4 | $949K | Buy |
+17,352
| New | +$823K | 0.01% | 1932 |
|
|
2019
Q3 | – | Sell |
-7,588
| Closed | -$295K | – | 5234 |
|
|
2019
Q2 | $284K | Buy |
+7,588
| New | +$239K | ﹤0.01% | 2602 |
|
|
2019
Q1 | – | Sell |
-1,916
| Closed | -$67.3K | – | 4928 |
|
|
2018
Q4 | $57K | Sell |
1,916
-1,060
| -36% | -$33.6K | ﹤0.01% | 3487 |
|
|
2018
Q3 | $106K | Buy |
+2,976
| New | +$92.3K | ﹤0.01% | 3494 |
|
|
2018
Q2 | – | Sell |
-9,608
| Closed | -$204K | – | 5178 |
|
|
2018
Q1 | $178K | Sell |
9,608
-34,200
| -78% | -$506K | ﹤0.01% | 2874 |
|
|
2017
Q4 | $629K | Buy |
43,808
+39,564
| +932% | +$514K | ﹤0.01% | 2071 |
|
|
2017
Q3 | $52K | Sell |
4,244
-7,396
| -64% | -$131K | ﹤0.01% | 3610 |
|
|
2017
Q2 | $213K | Buy |
11,640
+10,332
| +790% | +$191K | ﹤0.01% | 2600 |
|
|
2017
Q1 | $28K | Buy |
1,308
+844
| +182% | +$16.5K | ﹤0.01% | 3724 |
|
|
2016
Q4 | $7K | Buy |
+464
| New | +$8.22K | ﹤0.01% | 4024 |
|
|
2016
Q2 | – | Sell |
-1,216
| Closed | -$20.7K | – | 4677 |
|
|
2016
Q1 | $21K | Buy |
+1,216
| New | +$20.3K | ﹤0.01% | 3713 |
|
|
2015
Q4 | – | Sell |
-74,232
| Closed | -$1.54M | – | 4810 |
|
|
2015
Q3 | $1.59M | Buy |
74,232
+59,228
| +395% | +$1.32M | 0.02% | 932 |
|
|
2015
Q2 | $300K | Buy |
15,004
+9,600
| +178% | +$169K | ﹤0.01% | 2225 |
|
|
2015
Q1 | $84K | Buy |
+5,404
| New | +$81.7K | ﹤0.01% | 3003 |
|
|
2014
Q4 | – | Sell |
-21,252
| Closed | -$260K | – | 4972 |
|
|
2014
Q3 | $212K | Buy |
+21,252
| New | +$217K | ﹤0.01% | 2325 |
|
|
2014
Q2 | – | Sell |
-26,836
| Closed | -$238K | – | 5232 |
|
|
2014
Q1 | $277K | Buy |
26,836
+22,836
| +571% | +$236K | ﹤0.01% | 2159 |
|
|
2013
Q4 | $35K | Buy |
+4,000
| New | +$31.7K | ﹤0.01% | 3883 |
|
Other funds holding DXCM
Group One Trading's DXCM Position: Q2 2026 in Review
Group One Trading increased its DexCom (DXCM) stake by 548% in Q2 2026, buying an estimated $623K and bringing the position to 11,059 shares worth $745K. The position accounts for ﹤0.01% of the portfolio, ranked #3151.
Group One Trading first reported a position in DXCM in Q4 2013 and has held it in 35 quarters since. The position peaked at $17.3M in Q4 2020. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Group One Trading held 11,059 shares of DexCom worth $745K as of Q2 2026.
- Group One Trading bought 9,353 DexCom shares in Q2 2026, an estimated $623K.
- DexCom made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3151 holding.
- Group One Trading first reported a position in DexCom in Q4 2013 and has held it in 35 quarters since.
- Group One Trading's DexCom position peaked at $17.3M in Q4 2020.
- 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.